vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $34.3M, roughly 2.0× Clearfield, Inc.). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -3.2%). Inogen Inc produced more free cash flow last quarter ($-1.9M vs $-2.4M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

CLFD vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
2.0× larger
INGN
$68.6M
$34.3M
CLFD
Growing faster (revenue YoY)
INGN
INGN
+6.6% gap
INGN
3.4%
-3.2%
CLFD
More free cash flow
INGN
INGN
$506.0K more FCF
INGN
$-1.9M
$-2.4M
CLFD
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
INGN
INGN
Revenue
$34.3M
$68.6M
Net Profit
$-614.0K
Gross Margin
33.2%
51.4%
Operating Margin
-5.3%
-13.6%
Net Margin
-1.8%
Revenue YoY
-3.2%
3.4%
Net Profit YoY
67.8%
EPS (diluted)
$-0.04
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
INGN
INGN
Q4 25
$34.3M
$68.6M
Q3 25
$23.4M
$79.1M
Q2 25
$49.9M
$79.2M
Q1 25
$47.2M
$68.5M
Q4 24
$29.7M
$66.3M
Q3 24
$5.6M
$74.9M
Q2 24
$48.8M
$74.4M
Q1 24
$36.9M
$63.1M
Net Profit
CLFD
CLFD
INGN
INGN
Q4 25
$-614.0K
Q3 25
$-9.1M
$-5.3M
Q2 25
$1.6M
$-4.2M
Q1 25
$1.3M
$-6.2M
Q4 24
$-1.9M
Q3 24
$-6.0M
Q2 24
$-447.0K
$-5.6M
Q1 24
$-5.9M
$-14.6M
Gross Margin
CLFD
CLFD
INGN
INGN
Q4 25
33.2%
51.4%
Q3 25
53.2%
52.2%
Q2 25
30.5%
52.2%
Q1 25
30.1%
53.1%
Q4 24
29.2%
54.7%
Q3 24
55.2%
Q2 24
21.9%
57.4%
Q1 24
7.7%
54.5%
Operating Margin
CLFD
CLFD
INGN
INGN
Q4 25
-5.3%
-13.6%
Q3 25
10.3%
-9.0%
Q2 25
3.0%
-7.7%
Q1 25
0.6%
-11.2%
Q4 24
-6.9%
-17.2%
Q3 24
-10.4%
Q2 24
-4.7%
-9.5%
Q1 24
-26.4%
-25.8%
Net Margin
CLFD
CLFD
INGN
INGN
Q4 25
-1.8%
Q3 25
-38.8%
-6.7%
Q2 25
3.2%
-5.2%
Q1 25
2.8%
-9.0%
Q4 24
-6.4%
Q3 24
-8.0%
Q2 24
-0.9%
-7.5%
Q1 24
-16.0%
-23.1%
EPS (diluted)
CLFD
CLFD
INGN
INGN
Q4 25
$-0.04
$-0.26
Q3 25
$-0.65
$-0.20
Q2 25
$0.11
$-0.15
Q1 25
$0.09
$-0.25
Q4 24
$-0.13
$-0.41
Q3 24
$-0.25
Q2 24
$-0.04
$-0.24
Q1 24
$-0.40
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$96.4M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$249.7M
$192.2M
Total Assets
$268.1M
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
INGN
INGN
Q4 25
$96.4M
$103.7M
Q3 25
$106.0M
$106.5M
Q2 25
$117.2M
$103.7M
Q1 25
$112.0M
$118.9M
Q4 24
$113.0M
$113.8M
Q3 24
$129.0M
$105.7M
Q2 24
$123.8M
$97.9M
Q1 24
$142.9M
$107.4M
Total Debt
CLFD
CLFD
INGN
INGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$2.2M
Q2 24
$2.1M
Q1 24
Stockholders' Equity
CLFD
CLFD
INGN
INGN
Q4 25
$249.7M
$192.2M
Q3 25
$256.2M
$197.2M
Q2 25
$264.5M
$199.5M
Q1 25
$265.9M
$198.0M
Q4 24
$267.4M
$173.9M
Q3 24
$275.8M
$185.4M
Q2 24
$274.6M
$187.6M
Q1 24
$279.2M
$191.9M
Total Assets
CLFD
CLFD
INGN
INGN
Q4 25
$268.1M
$298.6M
Q3 25
$306.2M
$307.0M
Q2 25
$314.7M
$312.0M
Q1 25
$310.9M
$308.4M
Q4 24
$303.2M
$296.2M
Q3 24
$315.3M
$306.2M
Q2 24
$318.1M
$308.9M
Q1 24
$315.4M
$315.6M
Debt / Equity
CLFD
CLFD
INGN
INGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
0.01×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
INGN
INGN
Operating Cash FlowLast quarter
$-1.4M
$-943.0K
Free Cash FlowOCF − Capex
$-2.4M
$-1.9M
FCF MarginFCF / Revenue
-7.1%
-2.8%
Capex IntensityCapex / Revenue
2.9%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
INGN
INGN
Q4 25
$-1.4M
$-943.0K
Q3 25
$2.2M
Q2 25
$7.9M
$4.3M
Q1 25
$3.0M
$-16.8M
Q4 24
$7.2M
$-3.0M
Q3 24
$22.2M
$7.0M
Q2 24
$4.0M
$6.7M
Q1 24
$-5.7M
$-4.7M
Free Cash Flow
CLFD
CLFD
INGN
INGN
Q4 25
$-2.4M
$-1.9M
Q3 25
$1.6M
Q2 25
$7.5M
$3.7M
Q1 25
$654.0K
$-17.1M
Q4 24
$5.1M
$-3.3M
Q3 24
$18.2M
$5.3M
Q2 24
$2.8M
$6.6M
Q1 24
$-7.7M
$-6.1M
FCF Margin
CLFD
CLFD
INGN
INGN
Q4 25
-7.1%
-2.8%
Q3 25
2.0%
Q2 25
15.1%
4.6%
Q1 25
1.4%
-24.9%
Q4 24
17.1%
-5.0%
Q3 24
323.0%
7.1%
Q2 24
5.8%
8.9%
Q1 24
-20.8%
-9.6%
Capex Intensity
CLFD
CLFD
INGN
INGN
Q4 25
2.9%
1.4%
Q3 25
2.0%
0.7%
Q2 25
0.8%
0.9%
Q1 25
5.1%
0.4%
Q4 24
7.0%
0.5%
Q3 24
71.4%
2.2%
Q2 24
2.5%
0.1%
Q1 24
5.3%
2.1%
Cash Conversion
CLFD
CLFD
INGN
INGN
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons